Related Experiment Video
Updated: Jun 27, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Serum thyroglobulin determination in thyroid cancer patients
Zélia Francis1, Martin Schlumberger
1Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, University Paris Sud-XI, rue Camille Desmoulins, 94805 Villejuif Cédex, France.
Best Practice & Research. Clinical Endocrinology & Metabolism
|December 2, 2008
Summary
Serum thyroglobulin testing, alongside neck ultrasound, is crucial for monitoring thyroid cancer patients. Enhanced sensitivity methods improve detection after thyroid remnant ablation or TSH stimulation, aiding follow-up.
Area of Science:
- Endocrinology
- Oncology
- Medical Diagnostics
Background:
- Serum thyroglobulin (Tg) measurement is vital for thyroid cancer patient follow-up.
- Neck ultrasonography complements Tg testing in surveillance.
- Optimizing Tg sensitivity is key for effective patient management.
Purpose of the Study:
- To highlight the role of serum thyroglobulin in thyroid cancer follow-up.
- To discuss methods for improving Tg test specificity and sensitivity.
- To explore the impact of modern assay sensitivity on clinical practice.
Main Methods:
- Review of current clinical practices in thyroid cancer surveillance.
- Analysis of factors affecting serum thyroglobulin assay performance (e.g., thyroid remnant ablation, TSH levels).
- Discussion of advancements in Tg assay technology.
Main Results:
- Serum thyroglobulin, combined with neck ultrasonography, is central to thyroid cancer follow-up.
- Thyroid remnant ablation enhances the specificity of serum thyroglobulin testing.
- Optimal sensitivity is achieved with prolonged TSH withdrawal or recombinant human TSH (rhTSH) stimulation.
Conclusions:
- Serum thyroglobulin measurement is a cornerstone in post-thyroid cancer treatment monitoring.
- Technological advancements in functional sensitivity are improving the utility of Tg testing.
- Personalized strategies involving TSH manipulation and remnant ablation optimize surveillance efficacy.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...